BMS Broadens Market, De-Risks Long-Term Revenue Potential For Reblozyl

FDA Approves Drug’s Third US Indication And Its Biggest Yet

 
• By Mandy Jackson
  
man showing plaster after donation blood, blood transfusion
Reblozyl is approved in the first line for transfusion-dependent anemia in MDS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip